<DOC>
	<DOCNO>NCT01530256</DOCNO>
	<brief_summary>The purpose study determine safe tolerable , biologically active , potentially effective dos ( ) ALD518 subject acute GVHD , fail respond glucocorticosteroids , investigation Part B .</brief_summary>
	<brief_title>Exploratory Safety Study ALD518 Subjects With Steroid-refractory Acute Graft Versus Host Disease ( GVHD )</brief_title>
	<detailed_description />
	<criteria>Glucocorticosteroid refractory acute GVHD Grade 24 Prior corticosteroid therapy &gt; 1.0mg/kg methylprednisolone equivalent minimum 3 maximum 14 day Karnofsky Performance Satus Scale â‰¥ 50 % Adequate laboratory test screen Subjects Stage 1 skin acute GVHD Subjects Stage 3 4 liver GVHD Prior EBV associate malignancy Prior current Hepatitis B C Prior active tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>allograph</keyword>
	<keyword>steroid refractory</keyword>
</DOC>